Comparable Efficacy With Varying Dosages of Glucarpidase in Pediatric Oncology Patients

BACKGROUND: Glucarpidase rapidly reduces methotrexate plasma concentrations in patients experiencing methotrexate-induced renal dysfunction. Debate exists regarding the role of glucarpidase in therapy given its high cost. The use of reduced-dose glucarpidase has been reported, and may allow more ins...

詳細記述

保存先:
書誌詳細
出版年:Pediatr Blood Cancer
主要な著者: Scott, Jeffrey R., Zhou, Yinmei, Cheng, Cheng, Ward, Deborah A., Swanson, Hope D., Molinelli, Alejandro R., Stewart, Clinton F., Navid, Fariba, Jeha, Sima, Relling, Mary V., Crews, Kristine R.
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4770903/
https://ncbi.nlm.nih.gov/pubmed/25631103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25395
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料